Audrey Wang

Audrey Perng Yun Wang, MBA, currently serves as the Director of Financial Planning and Analysis at Antheia, Inc. since April 2023. Prior to this role, Audrey held the position of Associate Director, HBV Program Finance at Vir Biotechnology, Inc., where significant achievements included redesigning asset valuation models and leading budget and forecasting initiatives that resulted in substantial cost reductions. Previously at Merck, Audrey advanced through various roles including Associate Director of Financial Planning & Analysis and Sr. Specialist in the Corporate Strategy Office, driving financial efficiency and cross-divisional collaboration. Early career experiences include financial development at Cigna, research analysis at KGI Securities, and credit analysis at DBS Bank. Audrey holds an MBA from Washington University in St. Louis and a Bachelor of Business Administration in Finance from National Taiwan University.